All News #Library
Others
SIRPant Strengthens Board of Directors with Appointment of Roger Sawhney, M.D.
22 Jan 2024 //
GLOBENEWSWIRE
SIRPant Immunotherapeutics to Present Trial in Progress Poster at Annual Meeting
27 Sep 2023 //
GLOBENEWSWIRE
SIRPant Immunotherapeutics Appoints Jelle Kijlstra as Chief Medical Officer
11 Jul 2023 //
BUSINESSWIRE
FDA clears SIRPant IND to start Phase I non-Hodgkin lymphoma therapy trial
02 May 2023 //
CLINICAL TRIALS ARENA
SIRPant Immunotherapeutics Announces FDA Clearance of IND for SIRPant-
01 May 2023 //
BUSINESSWIRE

Market Place
Sourcing Support